Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02780531 · ClinicalTrials.gov registry record
Genetic and Blood Biomarkers in Neurological and Neuromuscular Diseases
A clinical trial of Neurological Disorders and Neuromuscular Disorders, sponsored by St. Louis University.
- Completed
- Registry status
- 20
- Enrollment target
- 1
- Study location
NCT02780531 is a study of Neurological Disorders and Neuromuscular Disorders that has completed, run by St. Louis University. The registered enrollment target is 20 participants, below the 33,532-participant average among 3 other Neurological Disorders trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02780531, a study of Neurological Disorders and Neuromuscular Disorders, has completed, sponsored by St. Louis University.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to identify genetic or other factors in the subjects blood that may predispose them to getting a particular disease or tell researchers how the disease will behave, for example how fast it will progress or what areas of the body might be affected. A second goal is to relate such factors to how such a condition affects the subjects clinically as well as how it affects the electrical functions of nerves and muscles.
Conditions Studied
Study Locations (1)
Missouri
- Saint Louis University Department of Neurology - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2015-12 |
| Est. Completion | 2018-10-17 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02780531
The ClinicalTrials.gov registry entry for NCT02780531 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 33,532-participant average among 3 other Neurological Disorders trials with a reported enrollment target (100% lower). The listed sponsor is St. Louis University, which has 107 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Neurological Disorders appearing as the primary indexed condition, and to 0 interventions.
NCT02780531 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.
Frequently Asked Questions
What is clinical trial NCT02780531 about?
NCT02780531 is a clinical study titled "Genetic and Blood Biomarkers in Neurological and Neuromuscular Diseases". The purpose of this study is to identify genetic or other factors in the subjects blood that may predispose them to getting a particular disease or tell researchers how the disease will behave, for example how fast it will progress or what areas of the body might be affected. A second goal is to rel...
What is the current status of trial NCT02780531?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2015-12. Estimated completion is 2018-10-17.
What conditions does trial NCT02780531 study?
This clinical trial studies the following conditions: Neurological Disorders, Neuromuscular Disorders.
Who is sponsoring clinical trial NCT02780531?
This trial is sponsored by St. Louis University, which has 107 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02780531 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Neurological Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.